Approval · Notice of Compliance 31575 · 2023
ZOLTROX: Notice of Compliance 31575
Issued September 7, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31575
- Date
- September 7, 2023
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- BAYCOX BOVIS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLTROX | 02541017 | Approved |
Medicinal ingredients
- TOLTRAZURIL 50 MG per ML